• Nurofen (ACCC) has ruled that British company Reckitt Benckiser , the manufacturer of The Australian Competition and Consumer Commission , should receive a $6m fine for misleading consumers over its “targeted” painkillers. The painkillers contained the same ingredients as the standard range but cost considerably more. In later this month , a federal court found the company guilty of “misleading conduct” and ordered the removal of the targeted pills from supermarket shelves. Reckitt Benckiser argued that “rational” customers would not believe the targeted products were more effective, but might choose them for “ease of selection”. A judge is expected to rule on the fine December . Meanwhile, the products have been withdrawn from sale and Nurofen ’s general painkillers carry a disclaimer.
Nurofen (ACCC) has ruled that British company Reckitt Benckiser , the manufacturer of The Australian Competition and Consumer Commission , should receive a $6m fine for misleading consumers over its “targeted” painkillers. The painkillers contained the same ingredients as the standard range but cost considerably more. In later this month , a federal court found the company guilty of “misleading conduct” and ordered the removal of the targeted pills from supermarket shelves. Reckitt Benckiser argued that “rational” customers would not believe the targeted products were more effective, but might choose them for “ease of selection”. A judge is expected to rule on the fine December . Meanwhile, the products have been withdrawn from sale and Nurofen ’s general painkillers carry a disclaimer.